NasdaqGS:ZVRAPharmaceuticals
Assessing Zevra Therapeutics (ZVRA) Valuation After Recent Share Price Moves And Rare Disease Milestone
Why Zevra Therapeutics Is On Investor Radar Today
Zevra Therapeutics (ZVRA) has drawn investor attention after recent trading, with the share price closing at US$9.23 and posting mixed short term returns alongside stronger total returns over the past 3 years.
See our latest analysis for Zevra Therapeutics.
The recent 7 day share price return of 7.51% and 1 day decline of 1.81% come after a period of steadier momentum. The 30 day share price return of 3.82% and the 3 year total shareholder...